December 15, 2024 - 13:36

A prominent academic from Tsinghua University has highlighted the urgent need for China's finance industry to provide greater support for technological innovation. In a recent statement, the scholar emphasized that the country is currently lagging behind the United States in fostering a vibrant tech ecosystem. This gap, they argue, could hinder China's long-term economic growth and competitiveness on the global stage.
To address this issue, the academic is advocating for increased funding directed towards high-tech firms. By channeling more financial resources into innovative startups and emerging technologies, China could stimulate creativity and drive advancements in various sectors. The call for action comes at a time when many countries are racing to lead in technology and innovation, making it crucial for China to bolster its support mechanisms for the tech industry.
The academic's remarks underscore the importance of collaboration between financial institutions and tech companies, suggesting that a stronger partnership could pave the way for groundbreaking innovations that benefit the economy as a whole.
May 14, 2026 - 12:10
ASX Penny Stocks To Watch: Bell Financial Group And Two OthersThe Australian share market has been under pressure lately, weighed down by the latest federal budget and ongoing global economic headwinds. Yet even in a down market, some investors are looking...
May 13, 2026 - 20:03
Should you buy Series I bonds as inflation heats up again?Series I bonds are once again drawing interest from savers looking for a secure way to protect their cash from rising prices. With inflation showing signs of heating up, these government-backed...
May 13, 2026 - 03:39
Nyxoah Reports First Quarter 2026 Financial and Operating ResultsNyxoah SA, a medical technology company developing treatments for Obstructive Sleep Apnea, reported its financial and operating results for the first quarter of 2026 on May 12. The company pointed...
May 12, 2026 - 00:33
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing CostsGilead Sciences, Inc. (GILD) recently saw its fiscal 2026 outlook take a significant hit, with analysts pointing to a massive $11.5 billion charge tied to in-process research and development (IPR&D...